You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cardiovascular conditions
  5. Acute coronary syndromes

Drug-eluting stents for the treatment of coronary artery disease

  • Technology appraisal guidance
  • Reference number: TA152
  • Published:  23 July 2008
  • Last updated:  18 November 2020
  • Guidance
  • Tools and resources
  • Information for the public
  • History
Download guidance (PDF)
  • Overview
  • 1 Guidance
  • 2 Clinical need and practice
  • 3 The technologies
  • 4 Evidence and interpretation
  • 5 Implementation
  • 6 Recommendations for further research
  • Appendix A: Appraisal Committee members and NICE project team
  • Appendix B: Sources of evidence considered by the Committee
  • Update information

6 Recommendations for further research

6.1 The Committee noted that there are a number of trials under way comparing the clinical effectiveness of DESs with their equivalent BMS and/or with other DESs at longer follow-up periods.


Next page Appendix A: Appraisal Committee members and NICE project team Previous page 5 Implementation